tradingkey.logo

Grifols SA

GRFS
9.410USD
+0.130+1.40%
交易中 美东报价延迟15分钟
2.42B总市值
15.48市盈率 TTM

Grifols SA

9.410
+0.130+1.40%

关于 Grifols SA 公司

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.

Grifols SA简介

公司代码GRFS
公司名称Grifols SA
上市日期May 17, 2006
CEOAbia (Jose Ignacio)
员工数量23833
证券类型Depository Receipt
年结日May 17
公司地址Parque Empresarial Can Sant Joan
城市SANT CUGAT DEL VALLES
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Spain
邮编08174
电话34935710000
网址https://www.grifols.com/
公司代码GRFS
上市日期May 17, 2006
CEOAbia (Jose Ignacio)

Grifols SA公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Tomas Daga Gelabert
Mr. Tomas Daga Gelabert
Other External Director
Other External Director
--
--
Mr. Raimon Grifols Roura
Mr. Raimon Grifols Roura
Vice Chairman of the Board, Proprietary Director
Vice Chairman of the Board, Proprietary Director
--
--
Ms. Nuria Martin Barnes
Ms. Nuria Martin Barnes
Non-Member Secretary of the Board of Directors
Non-Member Secretary of the Board of Directors
--
--
Mr. Ignacio Ramal Subira
Mr. Ignacio Ramal Subira
Chief Internal Audit & Enterprise Risk Management
Chief Internal Audit & Enterprise Risk Management
--
--
Mr. David Ian Bell
Mr. David Ian Bell
Chief Corporate Affairs and Legal Officer
Chief Corporate Affairs and Legal Officer
--
--
Mr. Inigo Sanchez-Asiain Mardones
Mr. Inigo Sanchez-Asiain Mardones
Independent Director
Independent Director
--
--
Mr. Victor Grifols Deu
Mr. Victor Grifols Deu
Proprietary Director
Proprietary Director
--
--
Ms. Enriqueta Felip Font
Ms. Enriqueta Felip Font
Independent Director
Independent Director
--
--
Ms. Maria Teresa Rione Llano
Ms. Maria Teresa Rione Llano
Chief Communications Officer
Chief Communications Officer
--
--
Mr. Daniel Fleta Coit
Mr. Daniel Fleta Coit
Chief Industrial Services Officer
Chief Industrial Services Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Tomas Daga Gelabert
Mr. Tomas Daga Gelabert
Other External Director
Other External Director
--
--
Mr. Raimon Grifols Roura
Mr. Raimon Grifols Roura
Vice Chairman of the Board, Proprietary Director
Vice Chairman of the Board, Proprietary Director
--
--
Ms. Nuria Martin Barnes
Ms. Nuria Martin Barnes
Non-Member Secretary of the Board of Directors
Non-Member Secretary of the Board of Directors
--
--
Mr. Ignacio Ramal Subira
Mr. Ignacio Ramal Subira
Chief Internal Audit & Enterprise Risk Management
Chief Internal Audit & Enterprise Risk Management
--
--
Mr. David Ian Bell
Mr. David Ian Bell
Chief Corporate Affairs and Legal Officer
Chief Corporate Affairs and Legal Officer
--
--
Mr. Inigo Sanchez-Asiain Mardones
Mr. Inigo Sanchez-Asiain Mardones
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q2
FY2021
FY2020
FY2019
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States/Canada
1.25B
57.30%
Rest of the World
469.41M
21.53%
European Union
461.58M
21.17%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 1月31日 周六
更新时间: 1月31日 周六
持股股东
股东类型
持股股东
持股股东
占比
Brandes Investment Partners, L.P.
11.31%
Capital World Investors
8.91%
Permian Investment Partners, LP
6.78%
Black Creek Investment Management, Inc.
3.90%
Millennium Management LLC
2.69%
其他
66.41%
持股股东
持股股东
占比
Brandes Investment Partners, L.P.
11.31%
Capital World Investors
8.91%
Permian Investment Partners, LP
6.78%
Black Creek Investment Management, Inc.
3.90%
Millennium Management LLC
2.69%
其他
66.41%
股东类型
持股股东
占比
Investment Advisor
29.46%
Hedge Fund
12.70%
Investment Advisor/Hedge Fund
6.36%
Research Firm
5.71%
Pension Fund
1.01%
Sovereign Wealth Fund
0.75%
Bank and Trust
0.14%
Family Office
0.03%
其他
43.84%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
347
144.63M
56.18%
-19.40M
2025Q3
327
150.82M
58.58%
-12.54M
2025Q2
305
150.67M
58.35%
-8.81M
2025Q1
318
151.56M
58.69%
-8.09M
2024Q4
317
145.36M
56.29%
-25.01M
2024Q3
302
144.07M
55.96%
-19.66M
2024Q2
298
148.36M
57.63%
-6.71M
2024Q1
295
140.29M
54.61%
+6.03M
2023Q4
303
126.55M
49.26%
-7.36M
2023Q3
316
123.59M
48.19%
-7.60M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Brandes Investment Partners, L.P.
29.12M
11.31%
+1.08M
+3.85%
Sep 30, 2025
Capital World Investors
22.93M
8.91%
+1.27M
+5.88%
Sep 30, 2025
Permian Investment Partners, LP
17.45M
6.78%
-1.18M
-6.31%
Sep 30, 2025
Black Creek Investment Management, Inc.
10.05M
3.9%
-2.52M
-20.08%
Sep 30, 2025
Millennium Management LLC
6.94M
2.69%
-2.73M
-28.24%
Sep 30, 2025
BofA Global Research (US)
3.99M
1.55%
+975.13K
+32.31%
Sep 30, 2025
Janus Henderson Investors
3.45M
1.34%
+250.17K
+7.82%
Sep 30, 2025
BMO Capital Markets (US)
2.90M
1.13%
+2.90M
--
Sep 30, 2025
Arrowstreet Capital, Limited Partnership
2.80M
1.09%
+2.22M
+383.69%
Sep 30, 2025
Harris Associates L.P.
2.73M
1.06%
-392.80K
-12.57%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
AdvisorShares Dorsey Wright ADR ETF
2.19%
Brandes International ETF
1.85%
Brandes US Small-Mid Cap Value ETF
1.85%
Capital Group International Core Equity ETF
0.18%
ProShares Ultra Nasdaq Biotechnology
0.13%
Invesco Nasdaq Biotechnology ETF
0.11%
iShares Biotechnology ETF
0.1%
ActivePassive International Equity ETF
0.08%
State Street SPDR S&P Kensho New Econ Comp ETF
0.03%
SPDR Portfolio Developed World ex-US ETF
0.01%
查看更多
AdvisorShares Dorsey Wright ADR ETF
占比2.19%
Brandes International ETF
占比1.85%
Brandes US Small-Mid Cap Value ETF
占比1.85%
Capital Group International Core Equity ETF
占比0.18%
ProShares Ultra Nasdaq Biotechnology
占比0.13%
Invesco Nasdaq Biotechnology ETF
占比0.11%
iShares Biotechnology ETF
占比0.1%
ActivePassive International Equity ETF
占比0.08%
State Street SPDR S&P Kensho New Econ Comp ETF
占比0.03%
SPDR Portfolio Developed World ex-US ETF
占比0.01%

分红派息

近5年累计派现 307.84M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Jul 30, 2025
GRFS.NB Final Cash Dividend of gross USD 0.175789 paid on Aug 20, 2025 going ex on Aug 12, 2025
Aug 12, 2025
Aug 20, 2025
Aug 12, 2025
May 25, 2021
GRFS.NB Interim Cash Dividend of gross USD 0.456586 paid on Jun 14, 2021 going ex on Jun 03, 2021
Jun 04, 2021
Jun 14, 2021
Jun 03, 2021
Oct 23, 2020
GRFS.NB Interim Cash Dividend of gross USD 0.201439 paid on Nov 09, 2020 going ex on Oct 30, 2020
Nov 02, 2020
Nov 09, 2020
Oct 30, 2020

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI